August 17, 2011 | Filed under: Health,News | Posted by:
The FDA today approved Zelboraf (vemurafenib) for the treatment of advanced or metastatic melanoma. The drug extends survival for the 50% of melanoma patients whose tumors carry the BRAF mutation.
Posted by
on August 17, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on August 17, 2011. Filed under